使用扩展的非侵入性风险评分,包括常规脏生物化学,提高了异常葡萄糖耐受性的预测

Jie He1, Baoqi Fan1,2, Eric S H Lau1

  • 1Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China.

PubMed
概括

改善糖尿病风险预测:采用常规生化学的新评分显著提高了异常葡萄糖耐受性个体的识别,有助于2型糖尿病预防工作.